Mimedx (MDXG) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.44% |
| Dec 31, 2025 | 25.97% |
| Sep 30, 2025 | 22.67% |
| Jun 30, 2025 | 19.95% |
| Mar 31, 2025 | 15.73% |
| Dec 31, 2024 | 11.98% |
| Sep 30, 2024 | 10.55% |
| Jun 30, 2024 | 7.14% |
| Mar 31, 2024 | 5.13% |
| Dec 31, 2023 | 5.77% |
| Sep 30, 2023 | -3.95% |
| Jun 30, 2023 | 5.34% |
| Mar 31, 2023 | 1.90% |
| Dec 31, 2022 | 0.84% |
| Sep 30, 2022 | -1.22% |
| Jun 30, 2022 | -0.32% |
| Mar 31, 2022 | 17.53% |
| Dec 31, 2021 | 15.22% |
| Dec 31, 2020 | 18.55% |
| Sep 30, 2020 | 6.08% |
| Jun 30, 2020 | -8.94% |
| Mar 31, 2020 | -5.53% |
| Dec 31, 2019 | 12.54% |
| Sep 30, 2019 | -0.44% |
| Jun 30, 2019 | -1.29% |
| Mar 31, 2019 | -15.36% |
| Dec 31, 2018 | -3.31% |
| Dec 31, 2017 | 3.53% |
| Sep 30, 2017 | 22.46% |
| Jun 30, 2017 | 32.45% |
| Mar 31, 2017 | 29.22% |
| Dec 31, 2016 | 11.46% |
| Sep 30, 2016 | 58.88% |
| Jun 30, 2016 | 63.81% |
| Mar 31, 2016 | 67.29% |
| Dec 31, 2015 | 56.91% |
| Sep 30, 2015 | 55.43% |
| Jun 30, 2015 | 60.62% |
| Mar 31, 2015 | 58.08% |
| Dec 31, 2014 | 59.17% |
| Sep 30, 2014 | 60.47% |
| Jun 30, 2014 | 52.44% |
| Dec 31, 2013 | 125.85% |